Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Medibank Private ( (AU:MPL) ) is now available.
Medibank Private Limited has released its financial results for the year ended 30 June 2025, reporting a 6.4% increase in revenue from ordinary activities, reaching $8.35 billion. The company declared a fully franked final ordinary dividend of 10.20 cents per share, reflecting its stable financial performance and commitment to returning value to shareholders.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.10 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is a prominent player in the health insurance industry, offering a range of health insurance products and services. The company focuses on providing comprehensive health coverage to its customers, positioning itself as a leading provider in the Australian market.
Average Trading Volume: 5,581,142
Technical Sentiment Signal: Buy
Current Market Cap: A$14.05B
Find detailed analytics on MPL stock on TipRanks’ Stock Analysis page.